AI Article Synopsis

  • A new series of heterocyclic compounds featuring a specific bicyclic structure were created and tested for biological activity.
  • The synthesis involved a Cu(I) catalyzed cycloaddition using starting materials that included a specialized alkyne and various nitrogen-containing azides.
  • Some of these compounds showed promising antiviral effects against Marburg and Ebola viruses, and their effectiveness may be linked to their ability to target lysosomes and their hydrophobic interactions.

Article Abstract

A new series of heterocyclic derivatives with a 1,7,7-trimethylbicyclo[2.2.1]heptane fragment was designed, synthesised and biologically evaluated. Synthesis of the target compounds was performed using the Cu(I) catalysed cycloaddition reaction. The key starting substances in the click reaction were an alkyne containing a 1,7,7-trimethylbicyclo[2.2.1]heptane fragment and a series of azides with saturated nitrogen-containing heterocycles. Some of the derivatives were found to exhibit strong antiviral activity against Marburg and Ebola pseudotype viruses. Lysosomal trapping assays revealed the derivatives to possess lysosomotropic properties. The molecular modelling study demonstrated the binding affinity between the compounds investigated and the possible active site to be mainly due to hydrophobic interactions. Thus, combining a natural hydrophobic structural fragment and a lysosome-targetable heterocycle may be an effective strategy for designing antiviral agents.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ardp.202300549DOI Listing

Publication Analysis

Top Keywords

177-trimethylbicyclo[221]heptane fragment
8
design synthesis and
4
synthesis and antiviral
4
antiviral evaluation
4
evaluation novel
4
novel conjugates
4
conjugates 177-trimethylbicyclo[221]heptane
4
177-trimethylbicyclo[221]heptane scaffold
4
scaffold saturated
4
saturated n-heterocycles
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!